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Objectives: To identify perceived influences on implementation of antibiotic stewardship
programmes (ASPs) in hospitals, across healthcare systems, and to exemplify the use of
a behavioral framework to conceptualize those influences.
Methods: EMBASE and MEDLINE databases were searched from 01/2001 to 07/2017
and reference lists were screened for transnational studies that reported barriers and/or
facilitators to implementing actual or hypothetical ASPs or ASP-supporting strategies.
Extracted data were synthesized using content analysis with the Theoretical Domains
Framework as an organizing framework. Commonly reported influences were quantified.
Results: From 3,196 abstracts 75 full-text articles were screened for inclusion. Eight
studies met the eligibility criteria. The number of countries involved in each study ranged
from 2 to 36. These studies included a total of 1849 participants. North America,
Europe and Australasia had the strongest representation. Participants were members
of special interest groups, designated hospital representatives or clinical experts. Ten of
the 14 theoretical domains in the framework were present in the results reported in the
included studies. The most commonly reported (≥4 out of 8 studies) influences on ASP
implementation were coded in the domain “environmental context and resources” (e.g.,
problems with data and information systems; lack of key personnel; inadequate financial
resources) and “goals” (other higher priorities).
Conclusions: Despite an extensive transnational research effort, there is evidence from
international studies of substantial barriers to implementing ASPs in hospitals, even in
developed countries. Large-scale efforts to implement hospital antibiotic stewardship
in those countries will need to overcome issues around inadequacy of information
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systems, unavailability of key personnel and funding, and the competition from other
priority initiatives. We have enhanced the evidence base to inform guidance by taking a
behavioral approach to identify influences on ASP uptake.
Systematic review registration: PROSPERO registration number CRD42017076425.
Keywords: antimicrobial stewardship, systematic review, barriers and facilitators, theoretical domains framework,
hospitals, behavior change
INTRODUCTION
Overuse or inappropriate use of antibiotics is a key driver of
the worldwide escalation of antibiotic resistance (Carlet et al.,
2011), which is a major threat to global public health and
patient safety. Antibiotic resistance is associated with excess
mortality and morbidity, prolonged hospital stay and increased
health care costs (De Kraker et al., 2011). Antibiotic resistance
has predominantly been a clinical problem in hospital settings
(Llor and Bjerrum, 2014), which are particularly susceptible to
harboring multidrug-resistant organisms (Chemaly et al., 2014).
Transnational response to this global crisis have been co-
ordinated by a World Health Organization Global Action Plan
(World Health Organization, 2015) and through a strategic
research agenda on antibiotic resistance, which currently unites
28 partners globally (JPIAMR, 2017). The global action plan
sets out five strategic objectives (World Health Organization,
2015): (1) improve awareness and understanding of antibiotic
resistance; (2) strengthen knowledge through surveillance and
research; (3) reduce the incidence of infection; (4) optimize the
use of antibiotic agents; and (5) ensure sustainable investment in
countering antibiotic resistance. A key approach to optimizing
the use of antibiotics is the deployment of antibiotic stewardship
programmes (ASP) in hospitals. An ASP involves a team
that implements a coherent set of actions that promotes the
responsible use of antibiotic agents (Dyar et al., 2017).
Effectiveness of ASPs implemented by hospitals is likely
to differ depending on both ASP elements and contextual
factors. In practice, ASP initiatives are a heterogeneous group
of system- and organization-based strategies and actions (Dyar
et al., 2017), and countries and organizations may vary
greatly in their capacity to deploy the necessary resources to
implement those interventions (Tiong et al., 2016). For example,
there is substantial transnational and even national variability
in appropriate prescribing and compliance with antibiotic
guidelines (Sandora et al., 2016; Turnidge et al., 2016; Dentan
et al., 2017; Mousavi et al., 2017). The international research
community faces the challenge of optimizing implementation
initiatives, such as ASPs, by producing generalisable evidence
that incorporates relevant theory and an understanding of the
contextual influences (Ivers and Grimshaw, 2016).
Amongst the key research gaps identified in the WHO action
plan is the need to understand the behaviors required to support
effective ASPs (WorldHealth Organization, 2015). The difference
between recommendations for appropriate antibiotic use (the
“what”) and behavioral change interventions (the “how”) is
key (Hulscher and Prins, 2017). ASPs require clinicians to
change their behaviors. There is a wealth of theoretical and
empirical evidence from the behavioral sciences about how to
change behavior, yet this is currently underutilized in antibiotic
stewardship studies (Charani et al., 2011; Rawson et al., 2017).
Hence there are opportunities to enhance the effects of ASPs
using behavioral approaches (Davey et al., 2017). Methods and
tools from the behavioral sciences should be used to select
the most promising interventions to change behavior, based
on a careful assessment of barriers and facilitators to practice
change (Davey et al., 2017; Hulscher and Prins, 2017). To date,
one systematic review has explored the evidence on barriers
and facilitators of antibiotic prescribing behavior in acute care
(Charani et al., 2011); however, an evidence synthesis using
behavior change theory to identify influences on implementation
of ASPs is lacking.
Aims and Objectives
The aim of this study was to inform the development of large-
scale contextually optimized quality improvement hospital ASPs,
by improving the understanding of contextual influences on ASP
implementation, through the framework of identifying “barriers
and facilitators.” The objectives were:
1. To conduct a systematic review of transnational research
to identify commonly perceived barriers and facilitators to
implementation of actual or hypothetical ASPs in hospitals.
2. To provide an exemplar of the use of a behavioral framework
analysis to conceptualize identified barriers and facilitators to
ASPs in hospitals.
METHODS
This systematic review was conducted in accordance with
the Center for Reviews and Dissemination’s guidance for
undertaking reviews in healthcare (Centre for Reviews
Dissemination, 2009) and reported adhering to the PRISMA
guidelines (Liberati et al., 2009).
Search Strategy
A search strategy was developed by an Information Specialist
in collaboration with the review authors, who generated a list
of possible relevant keywords related to antibiotic stewardship,
hospital settings and national or international study scope. The
search strategy was not intended to be restrictive to a specific
study design, but excluded studies on animals, and editorials and
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abstracts. The review team screened a random sample of 100
identified abstracts to verify if relevant studies were identified.
Based on the results of this verification and a study protocol,
the search string was amended so that the search became more
sensitive to data on barriers and facilitators and infection control
and antibiotic policies research. A new search was performed
and achieved satisfactory comprehensiveness such that no further
amendments were applied. The final search strategy can be found
in the protocol.
Data Sources
An initial scoping search for published literature was performed
using the Medline and EMBASE electronic bibliographic
databases. There was no start date limit; the EMBASE
and Medline databases were searched from 1980 and 1946
respectively to 18th July 2017. We observed a sudden increase
in numbers of identified studies published after 2000. The first
global strategy to lead the response of 193 United Nation states to
antibiotic resistance was developed by the WHO in 2001 (World
Health Organization, 2001). The first guideline for designing an
ASP was published by the Society for Healthcare Epidemiology
of America (SHEA) and Infectious Diseases Society of America
(ISDA) in 2007 (Dellit et al., 2007). Consequently, we included
only the papers published between 2001 and 18th July 2017.
References of retrieved articles, systematic reviews and personal
files were searched for relevant studies.
Study Selection
A random sample of 100 titles and abstracts was double screened
by two reviewers (EMD and MR) to assess consistency, and
revisions were made to the definitions and criteria to enhance
clarity. In the next, single screening phase, the same two reviewers
independently screened the remaining titles and abstracts
using an Excel spreadsheet. For record keeping purposes, we
documented details of excluded abstracts, including topic, scope
(country-level or international), setting, participants and design.
Five randomly selected full-text articles were double screened
for inclusion by two reviewers (MR, CRR) to assess reliability.
Disagreements were resolved by discussion and the remaining
selected full-text articles were assessed by one reviewer (MR),
with any uncertainties related to eligibility of a specific article
resolved by discussion with a second reviewer (CRR or EMD).
Inclusion Criteria
Studies were included in the systematic review if they met the
following eligibility criteria:
• Transnational studies, i.e., in which participants were from
more than one country, were included.
• Studies on ASPs or specific antibiotic stewardship strategies
used to support ASPs, such as selective reporting of antibiotic
susceptibility test (AST) results (a laboratory-based ASP
intervention which consists of reporting to prescribers only
few antibiotics or not reporting at all when colonization is
likely) (Barlam et al., 2016).
• Reported primary data published in full-text articles, from
structured (e.g., questionnaires with specific response
formats) and semi-structured (open-ended questions)
methods of inquiry.
• Settings included hospital inpatient care settings or mixed
hospital inpatient and outpatient settings.
• Reported barriers and/or facilitators to implementing an
ASP. Studies which did not use the terms “barriers”
and “facilitators” explicitly were included when they used
associated terms such as “issues,” “difficulties,” “problems
with,” “(in)adequacy of support for an ASP,” “obstacles,”
“enablers,” “solutions.”
• There were no restrictions for languages.
Exclusion Criteria
We excluded review articles, guidelines, studies focused on
antimicrobials other than antibacterials (i.e., antituberculous,
antifungal, antiparasitic, antiviral drugs), and studies of patients
from ambulatory care or long-term healthcare settings.
Data Extraction
For each included study, one reviewer (MR) completed data
extraction using a data extraction spreadsheet to include the
following information: methods (author, study design, study
response rate), population (country, type of hospital setting
and participants, sample size), description of an ASP; barriers
and facilitators to implementation (a method of assessment,
response rate to a question, results verbatim including type and
quantification (e.g., rates or ranks). A second reviewer (EMD)
double-checked the extracted information. In one case a study
author was contacted via e-mail to obtain additional information
that was not reported in the published article.
Appraisal of Methodological Quality of
Included Studies
We used relevant parts of the Mixed Methods Appraisal Tool
(MMAT) (Pluye et al., 2011) to conduct quality appraisal.
Specifically, if the research questionwas judged to be clear and the
data collection methods were judged to be appropriate, further
methodological appraisal was undertaken. For quantitative
studies, four criteria (sampling strategy, representativeness,
appropriateness of measurement and response rate) were
applied. Two reviewers (EMD and MR) independently assessed
themethodological quality of each included study by scoring each
study against each MMAT item with the following nominal scale:
yes (clearly met), no (clearly not met) and unclear (not clear if
met) resolving disagreements by discussion.
Data Synthesis and Presentation
Qualitative analysis was conducted using theory-based content
analysis, which involves a directed approach to content analysis
(a systematic method of making specific inferences from
differential levels of text) (Hsieh and Shannon, 2005). Levels
of text can be broadly divided into primary content (i.e.,
themes and main ideas of the text) and latent content (i.e.,
context information) (Vaismoradi et al., 2013). We applied
the Theoretical Domains Framework (TDF), a theoretical
framework, developed by synthesizing behavioral theories
through a systematic consensus process, as a framework for
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investigating the barriers and facilitators to behavior (Cane
et al., 2012). TDF is a synthesis of 33 theories of behavior
and behavior change clustered into 14 (originally 12) domains
(Cane et al., 2012). It has been applied across a range of
healthcare systems and healthcare behaviors (Atkins et al., 2017).
Two reviewers (EMD and MR) jointly coded the barriers and
facilitators reported within the studies into domains of the
TDF (the coding manual, including detailed descriptions of 14
domains and their underlying constructs, is included in the
Supplementary Materials). Two codes were applied to the same
extract if applicable. All codified extracts were then reviewed and
discussed with a third reviewer with expertise in the TDF (JJF). In
the next step of analysis the same reviewers (MR, EMD, JJF) used
an inductive approach to identify subthemes (specific barriers
and facilitators), within the coded domains of the TDF.
For the quantitative summary, the numbers of studies in
which subthemes of barriers or facilitators were nominated or
endorsed by participants were totalled. This do not reflect how
many respondents cited the specific barriers/facilitator within
studies. Subthemes that were reported in the majority (≥50%)
of identified studies are referred to as ‘most commonly reported’
influences on ASP use.
RESULTS
Search Results
The flow chart of the search and screening results is presented in
Figure 1. Briefly, from 3,196 abstracts within the specified date
limits, 75 full-text articles were screened for inclusion, of which
67were excluded. Reasons for exclusionwere: no full-text (n= 1),
no original data (n = 11), not transnational (n = 15), study
setting (n= 3), type of participants (n= 4), not an ASP (Charani
et al., 2011), barriers or facilitators unreported (n = 18). Eight
studies met the criteria and were included in this review (Itokazu
et al., 2006; Johannsson et al., 2011; Howard et al., 2015; Bryant,
2015; Fleming et al., 2015; Livorsi et al., 2016; Wolf et al., 2016;
Pulcini et al., 2017).
Participants
All eight included studies were cross-sectional surveys. These
studies included a total of 1849 participants, with sample sizes
ranging from 14 (Bryant, 2015) to 660 (Howard et al., 2015). Two
studies involving 704 participants reported individual participant
level data (Itokazu et al., 2006; Johannsson et al., 2011). Five
studies involving 1,057 institutions reported institutional level
data (Howard et al., 2015; Bryant, 2015; Fleming et al., 2015;
Livorsi et al., 2016; Wolf et al., 2016). One study reported
country-level data and included national representatives of 36
countries (Pulcini et al., 2017). Two studies did not report
numbers of respondents per country (Itokazu et al., 2006;
Bryant, 2015) and one study provided incomplete information
on a geographic location of participating institutions (Livorsi
et al., 2016). The number of countries involved in each study
ranged from 2 to 36, but overall participants from the North
America, Europe and Australasia had the stronger representation
in the identified studies. Participants were members or associates
of established special interest groups or designated hospital
representatives or ASP experts in charge at their hospitals. The
characteristics of included studies and participants are presented
in Table 1.
Characteristics of Antibiotic Stewardship
Programmes
Six studies explored barriers or facilitators to specific ASPs
(Itokazu et al., 2006; Johannsson et al., 2011; Howard et al.,
2015; Bryant, 2015; Wolf et al., 2016). Between 58% and 99%
of respondents were from an institution with an ongoing ASP.
Two studies referred to specific antibiotic stewardship strategies:
audit and feedback (Livorsi et al., 2016), and selective reporting
of antibiotic susceptibility test (AST) results (Pulcini et al.,
2017). Respondents in the study on audit and feedback had
to be engaged in this strategy to be eligible for participation
(Livorsi et al., 2016). One study was restricted to ASP in
pediatric oncology and bone marrow transplant (Wolf et al.,
2016). Moreover, in one study (Bryant, 2015) pediatric hospitals
accounted for half of included hospitals.
Measures of Barriers and Facilitators
Seven studies examined barriers to antibiotic stewardship
programmes or strategies (Itokazu et al., 2006; Johannsson et al.,
2011; Howard et al., 2015; Bryant, 2015; Livorsi et al., 2016; Wolf
et al., 2016; Pulcini et al., 2017) and one study reported possible
facilitators (Fleming et al., 2015). One study asked participants to
report solutions they employed to address experienced barriers,
but findings related to this question were not reported (Pulcini
et al., 2017). None of the studies explored the impact of health
system factors (e.g., public vs. private healthcare systems). Three
studies considered the impact of country context on reported
barriers and facilitators (Howard et al., 2015; Fleming et al., 2015;
Wolf et al., 2016). Five studies used closed-ended questions (i.e.,
a multiple-selection list of options) on barriers with prelisted
response options (Itokazu et al., 2006; Johannsson et al., 2011;
Howard et al., 2015; Bryant, 2015; Wolf et al., 2016). Three
studies used open-ended questions to identify barriers and/or
facilitators, one reported identified themes only (Livorsi et al.,
2016) and two reported both themes and exemplary quotations
(a qualitative component) (Howard et al., 2015; Fleming et al.,
2015). Amongst studies that used closed-ended questions on
barriers, two did not detail methods of questionnaire design
(Itokazu et al., 2006; Johannsson et al., 2011), one used an
amended questionnaire from a previously conducted survey
based on literature search and expert opinion (Bryant, 2015),
two searched literature, of which one also used expert advice
(Howard et al., 2015) and one a focus group (Wolf et al., 2016).
Only one of the three studies that used open-ended questions
on barriers reported the method of data analysis (Pulcini et al.,
2017), namely the framework method proposed by Flottorp
et al. (2013). Overall, comprehensiveness and precision of the
methods of how studies identified barriers and facilitators used
was limited.
Methodological Quality of Included Studies
Details of the Mixed Methods Appraisal Tool (MMAT) (Pluye
et al., 2011) quantitative descriptive subsection scoring are
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FIGURE 1 | Study flow diagram.
presented for each study in Table S1. All included studies
fulfilled the two screening criteria in the MMAT, suggesting
that further methodological appraisal was feasible. All eight
studies used an appropriate sampling strategy. The main
methodological limitation was appropriateness (i.e., clear origin
or known validity or standard measurement) of methods
of assessing barriers and facilitators, with six studies not
meeting this criterion (details in Table S1 footnote). Six
studies scored negative or unclear on adequate response rate
and four on representativeness, raising concerns of possible
selection bias.
Qualitative Synthesis
All barriers and facilitators were coded from the eight included
studies into theoretical domains of the TDF. A summary of
identified themes and subthemes of influences is presented in
Table 1. Results of this coding can be found in Table S2. Data
extracts coded into subthemes of TDF domains can be found
in Table S3. Ten of the 14 domains of the TDF were present
in the results reported in the eight studies (as presented in
Table 2—“Optimism,” “emotion,” “memory, attention and decision
processes” and “beliefs about capabilities” were not present in
any of the results reported). Subthemes within each domain are
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Country NA Selective reporting of antibiotic
susceptibility test results (NC)
EUCIC, European Committee on Infection Control; EUCAST, European Committee on Antimicrobial Susceptibility Testing; NC, not clear, SHEA, the Society of Healthcare Epidemiology
of America; SRN, the Healthcare Epidemiology of America Research Network; PIDS, the Paediatric Infectious Diseases Society; SIDP, Society of Infectious Diseases Pharmacists.
UAustria, Azerbaijan, Belgium, Bosnia, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Kosovo, Latvia,
Macedonia, The Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, Turkey, UK, Ukraine.
described below, commencing with the domain with the largest
number of subthemes.
Environmental Context and Resources
There was a perceived paucity of funding (Johannsson et al.,
2011; Howard et al., 2015; Pulcini et al., 2017) and accordingly
securing financial resources to develop and implement ASPs was
mentioned as a facilitator (Fleming et al., 2015).
Insufficient pharmacist and clinician time allocated to ASP
activities was also reported to hinder ASP efforts (Itokazu et al.,
2006; Livorsi et al., 2016; Wolf et al., 2016). Conceptually related
to this issue was a reported shortage of key personnel (Itokazu
et al., 2006; Johannsson et al., 2011; Howard et al., 2015; Bryant,
2015; Livorsi et al., 2016; Pulcini et al., 2017), such as dedicated
infectious disease clinicians, pharmacists or pharmacy staff,
and microbiologists.
A range of barriers related to data and information systems
availability and support were identified (Itokazu et al., 2006;
Johannsson et al., 2011; Howard et al., 2015; Livorsi et al.,
2016; Wolf et al., 2016) that resulted in poor access to patient
information (Johannsson et al., 2011; Howard et al., 2015; Pulcini
et al., 2017). Participants cited problems of inadequate quality
of clinical data on the current use of antimicrobials (Livorsi
et al., 2016) and insufficient data analysis resources (Wolf et al.,
2016). Given the absence of dedicated information technology
staff to support the selective reporting of AST results, additional
technical support to manage the data was required. Lack of
such support was seen to increase the workload for information
technology staff (Pulcini et al., 2017).
Setting- and context-specific barriers included a lack of
a reliable supply of laboratory provisions (i.e., shortage of
laboratory materials) for selective reporting of antibiotic
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TABLE 2 | A summary of barriers (B) and facilitators (F) to implementing an antibiotic stewardship programme (ASP) or an ASP-supporting strategy.
Theoretical domains
framework–domains




(B) Lack of key personnel (e.g., infectious disease clinicians, pharmacy staff, microbiologist) 6
(B) Problems with data and information systems (e.g., inadequate information technology, lack of dedicated IT assistant,
lack of good quality data, and resources to utilize it)
6
(B, F) The influence of adequacy of financial resources 4
(B) Lack of time 3
(B) Inadequate supply of laboratory provisions 1
(B) Problem of limited antibiotic options available in settings with prevalent multi drug resistant bacteria 1
Goals (B) Other higher priority initiatives hindering the ASP’s use 4
Social influences (B) Resistance from medical staff 3
(B, F) The influence of clinical leadership (e.g., pharmacists, infectious diseases physicians, senior clinicians) 3
(B) Lack of leadership from hospital administration 3
(B) Poor communication, including interpersonal, within teams (e.g., inconsistency or conflict) and between private and
public sectors
3
(B) Perceived unhelpful attitudes of oncology clinicians 1
Behavioural regulation (B, F) The influence of local guidelines and clinical practice protocols 2
(F) Electronic prescribing as a mean to effectively change prescribing patterns by providing easier and quicker feedback 1
(B) Lack of national and/or international standards required for a specific antibiotic stewardship strategy 1
(B) Lack of standards for measuring performance of a specific antibiotic stewardship intervention 1
Knowledge (B) Lack of knowledge of patient test or results 3
(B) Lack of knowledge about ASPs (e.g., due to poor education or inevitable loss of knowledge due to high staff turnover) 2
(B) Lack of knowledge of current use of antibiotics 1
Beliefs about consequences (B) Lack of certainty about usefulness of an ASP or a specific antimicrobial stewardship strategy 2
(B) ASP clinicians’ belief in competing consequences of managing infections in different patient groups acting as a barrier 1
(F) Focussing ASPs efforts on serious infectious disease as a mean to improving effectiveness of ASPs 1
Social/professional role and
identity
(B) ASP derived jurisdiction gives antimicrobial stewardship clinicians limited power or authority 1
(B) Uncertainties around overlapping responsibilities between multiple infectious diseases groups within a hospital 1
Intentions (B) Lack of willingness to change 1
Reinforcement (B) A specific antimicrobial stewardship strategy not being covered by a reimbursement system 1
Skills (B) Medical professionals lacking relevant skills for a specific antimicrobial stewardship strategy (e.g., training in clinical
microbiology)
1
susceptibility testing (Pulcini et al., 2017), and the challenge of
limited availability of antibiotic options faced by ASPs in hospital
settings wheremulti-drug resistant bacteria are prevalent (Pulcini
et al., 2017).
Social Influences
Interpersonal processes among healthcare professionals
(including communication, cooperation and leadership)
influenced ASP implementation. Poor communication was
reported (Livorsi et al., 2016; Wolf et al., 2016; Pulcini et al.,
2017), including within infectious disease and ASP teams (Wolf
et al., 2016), between staff (e.g., antibiotic stewardship and
pediatric oncology clinicians) (Wolf et al., 2016) and between
public and private hospital systems (Pulcini et al., 2017). Studies
also reported a lack of cooperation and even resistance from
medical staff (Itokazu et al., 2006; Johannsson et al., 2011;
Howard et al., 2015; Livorsi et al., 2016). An unsatisfactory
relationship between antibiotic stewardship clinicians working
in pediatric oncology settings and pediatric oncology clinicians
was characterized by role conflict and lack of trust or shared
beliefs (Wolf et al., 2016). Finally, a lack of leadership from
hospital administrators (Itokazu et al., 2006; Howard et al., 2015;
Bryant, 2015) and a lack of clinical leadership from pharmacists
and infectious diseases clinicians were perceived to be barriers
(Itokazu et al., 2006; Bryant, 2015). Participants suggested that
the latter could be overcome by introducing a microbiologist
team leader to facilitate the establishment of an antibiotic
stewardship team (Fleming et al., 2015).
Behavioral Regulation
Availability of adequate guidance documents or
recommendations at all levels (strategy-specific national
and international, local, and setting-specific) influenced
implementation of ASPs. A lack of national or international
clinical practice guidelines to set professional standards
for applying the selective reporting of AST results acted
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as a barrier (Pulcini et al., 2017). The selective reporting
of AST results was reported to be particularly difficult in
complicated cases (e.g., polymicrobial infections, severe
infections, pharmacodynamics or pharmacokinetics factors)
(Pulcini et al., 2017). As susceptibility testing occurs in vitro,
this difficulty might be related to a need for specific guidance
with accounting for many in vivo factors (e.g., pharmacokinetics
factors) that can influence treatment success. Depending on
the stage of ASP implementation, finalizing local guidelines on
existing ASP efforts and developing implementation strategies
was reported to be potentially helpful with implementing ASPs
(Fleming et al., 2015). In pediatric oncology settings, insufficient
input of antibiotic stewardship clinicians into clinical practice
guidelines, and oncology clinicians following externally derived
treatment pathways, were reported to be barriers to stewardship
(Wolf et al., 2016).
Influences on behavioral regulation related to audit and
feedback were also identified. A lack of performance metrics
needed for audit and feedback was reported (Livorsi et al.,
2016). Developing processes for the implementation of audit and
feedback was cited to be potentially beneficial for implementation
of ASPs (Fleming et al., 2015). To optimize feedback needed
for adjusting prescribing patterns and to improve patient
monitoring, the introduction of an electronic prescribing system
was felt to be possibly useful (Fleming et al., 2015).
Knowledge
Studies indicated that limited access to relevant education
(Bryant, 2015; Pulcini et al., 2017) and high level of turnover of
junior staff was felt to be associated with an inevitable leakage
and loss of ASP knowledge (Bryant, 2015). Insufficient knowledge
about antibiotic resistance or clinical microbiology are examples
of gaps in scientific background reported by participants (Pulcini
et al., 2017). Lack of knowledge about patient clinical data (e.g.,
insufficiency of patient clinical data in a laboratory and delays in
obtaining results) (Johannsson et al., 2011; Howard et al., 2015;
Pulcini et al., 2017) and the current use of antimicrobials (Livorsi
et al., 2016) were also identified.
Beliefs About Consequences
A lack of awareness among hospital administrators about the
current value of ASPs was reported to hinder the delivery of
functional and effective stewardship (Johannsson et al., 2011).
Similarly, some unawareness of the value of the selective
reporting of AST results and conflicting evidence on its
usefulness, effectiveness or applicability were felt to impede its
implementation (Pulcini et al., 2017).
Participants expressed the opinion that effectiveness of
ASP efforts would further benefit from narrowing focus to
serious infections, extended spectrum beta-lactamase-producing
organisms, or carbapenem- and vancomycin-resistant organisms
(Fleming et al., 2015).
Social/Professional Role and Identity
Uncertainty around division of responsibilities between multiple
infectious diseases professional groups was identified, but only
in one study, and its participants ranked it as the least common
barrier (Johannsson et al., 2011).
Goals
The selective reporting of AST results was reported to be
hindered by a lack of support in current ASP guidelines (Pulcini
et al., 2017). Studies also reported other higher priority initiatives
competing with establishing and maintaining ASPs (Johannsson
et al., 2011; Howard et al., 2015; Pulcini et al., 2017). Populations
other than immunocompromised hosts having higher priority
in antibiotic stewardship programmes, was considered to be an
important barrier by antibiotic stewardship clinicians (Wolf et al.,
2016).
Intentions
A lack of willingness to change behavior was felt to hinder ASP
implementation efforts (Bryant, 2015).
Reinforcement
A lack of incentives to use selective reporting of ASTwas reported
to impede its implementation (Pulcini et al., 2017).
Skills
It was felt that local professionals are generally lacking relevant
skills (especially physicians’ clinical microbiology skills) needed
for the selective reporting of AST results (Pulcini et al., 2017).
Quantitative Summary
The most commonly reported (≥4 out of 8 studies) influences on
ASP implementationwere coded into the domain “environmental
context and resources”: problems with data and information
systems (e.g., inadequate information technology, lack of
dedicated information technology assistance, lack of good quality
data and resources to utilize it), lack of key personnel (e.g.,
infectious disease clinicians, pharmacy staff, microbiologist) and
inadequacy of financial resources. In addition, other higher
priority initiatives hindering the implementation of ASPs were
coded into the domain “goals”) (Table 1).
Country Context
One paper in this review (Wolf et al., 2016) found no effect of
continent when comparing North American and Australasian
institutions. Another included paper (Howard et al., 2015)
concluded that a lack of funding or personnel and a lack of
information technology or ability to acquire data (all coded into
the domain “environmental context and resources”), followed
by prescriber opposition (“social influences”) or other higher
priorities (“goals”) were the top barriers to implementing an
ASP, uniformly across all continents except for Africa, for which
information technology was ranked as the main barrier. In
hospitals that planned to develop an ASP, the main barrier
was a lack of funding, except in South America, where a
lack of awareness on the part of the hospital administration
(“social influences”) that implies a lack of leadership from
hospital administration, was the key barrier stated (Howard
et al., 2015). “Behavioural regulation” strategies such as finalizing
local guidelines on existing ASP efforts, developing processes
for the implementation of ASP strategies and introducing an
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electronic prescribing system to adjust prescribing patterns
were key strategic enablers of ASPs suggested by the UK, but
not Irish respondents (Fleming et al., 2015). Ring-fencing of
financial resources (“environmental context and resources”) and
a need for microbiologist leadership (“social influences”) were
mentioned by respondents from Ireland, but not from the UK
(Fleming et al., 2015).
DISCUSSION
In response to calls for improved understanding of contextual
influences on the implementation of ASP in hospitals (World
Health Organization, 2015; Davey et al., 2017; Hulscher and
Prins, 2017), we conducted a systematic review of transnational
studies on reported barriers and facilitators to implementation
of ASP in hospitals. Except for one study, most of the data
comes only from developed countries (North America, Europe
and Australasia). Reported barriers and facilitators were coded
using the TDF, a framework based on behavioral theories.
None of the included studies used behavioral theory explicitly
to identify barriers and facilitators, reiterating the problem
of behavioral approaches being underutilized in antibiotic
stewardship studies (Charani et al., 2011; Rawson et al., 2017)
and highlighting the importance of efforts to enable their
widespread use (Atkins et al., 2017). The most commonly
reported influences on ASP implementation included problems
with data and information systems, lack of key personnel and
financial resources. Another commonly reported barrier was
the effect of conflicting priority initiatives. Between-country
differences in the order of importance of specific influences on
ASP implementation efforts warrant further investigation.
The main methodological weakness of included studies
concerned the methods used in these studies to identify
barriers and facilitators. Five studies used a list of options
for barriers compiled by study authors and three studies
used open-ended questions, hence barriers and facilitators
were not comprehensively captured. It is unclear to what
extent methods of assessment affected types of reported
barriers. Two of three studies with high scores on quality of
measurement of barriers were strategy- and context-specific and
this possibly enabled participants to recall specific episodes or
information more accurately. There were difficulties with quality
of reporting, including the use of vague wording, incomplete
descriptions and limited space dedicated to reporting barriers
and facilitators. Frontline hospital workers involved in ASPs were
rarely represented.
The review itself has its strength and limitations. By
using TDF, a well-operationalized, multi-level implementation
determinant framework derived from theory, we synthesized
generic learning from diverse studies on dissimilar, context-
specific multi-component ASPs, which may be useful to
research teams designing future large-scale evaluation efforts.
Other frameworks promote knowledge synthesis about what
works, where and why, across multiple contexts, such as the
Consolidated Framework For Implementation Research (CFIR)
(Damschroder et al., 2009). However, given all included studies
involved interventions to change antibiotic prescribing behavior,
a behavioral approach using TDF was a suitable means of
providing a high level of elaboration for contextual influences
related to both individual-level change (provider behavior) and
collective-level constructs. With a recognized need for the use
of behavioral theory approaches (Davey et al., 2017; Rzewuska
et al., 2019), the high level of transparency in our reporting of
the review methods enhances existing guidance (Atkins et al.,
2017). For example, a user less familiar with the TDF may
find it easier to apply it, by following the outputs from each
step of the analytic process reported in this paper. A limitation
of the review is that, although we searched several databases
using a comprehensive search strategy, we included only research
published in English. Hence, the findings may not generalize
beyond English language contexts.
The scope of our review has important implications. First,
antibiotic stewardship involves different “actors,” including
individuals (e.g., antibiotic prescribers), organizations and
governments (Dyar et al., 2017). By focusing on hospital staff
experiences with implementation of ASPs, we took a focused
approach that is an organization level approach. Several factors
are known to influence prescribing behavior in acute care
hospital settings (Md Rezal et al., 2015), hence a need for
understanding a context of antibiotic stewardship (Tamma et al.,
2014). A methodological reason for taking a focused approach
was that the framework method of analysis, thematic analysis
and qualitative content analysis, involve categorization, which
in turn requires data that is specified at a similar level (Gale
et al., 2013). Second, we reasoned that there are qualities of
the whole that cannot be reduced to the qualities of its parts
and yet the nature of a part depends upon the whole in which
it is embedded (Wagemans et al., 2012). As such we were
interested in comparing multi-component ASPs (“whole”) with
individual ASP-supporting interventions (“parts”). However,
we aimed in this work to learn about implementation of
ASPs, as opposed to conceptualizing individual behavior change
interventions (“parts”). For an example of “why” and “how”
the TDF can increase clarity and help to operationalise the
individual intervention elements, we refer a reader to another
paper published by the authors (Duncan et al., 2020). At last,
to fully address the remaining uncertainties surrounding the
value of antibiotic stewardship, we advocate for robust large-
scale participatory collaborative evaluation research (Grimshaw
et al., 2019; Rzewuska et al., 2019). Finding a balance between
full and consistent implementation across multiple contexts,
while providing the flexibility for individual sites to adapt the
intervention as needed, is a major task (Damschroder et al.,
2009). Multinational trials will face the design challenge of setting
minimum conditions addressing differences between countries
that are likely to generate unintended influences (barriers
and facilitators) on outcomes and, thus, potentially hinder
the generalisability and transferability of results. Therefore, we
reasoned that commonalities captured through transnational
studies would inform us about a broad scope of circumstances
and characteristics that should be considered when facing
early methodological issues, such as defining the scope of
the evaluation and selecting study sites (Bryce et al., 2005).
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Country-level studies seem to be highlighting similar barriers.
For example, quantitative analysis of data from three nationwide
studies in the USA (Doron et al., 2013) and Australia (Chen et al.,
2011; James et al., 2015) identified the same barriers as those
reported in the current review. Chen and colleagues (Chen et al.,
2011) concluded that barriers identified through quantitative
and qualitative methods were alike. Overall, transnational studies
were unlikely to use qualitative methods of data collection, which
would seem to be more appropriate in the context of studies in
which face-to-face methods of data collection are more feasible
(Cotta et al., 2015; James et al., 2015).
Work presented in this review has the potential to inform local
or regional initiatives to guide ASP implementation efforts. We
have provided a detailed coding manual so that future initiatives
may be informed by this behavioral approach.
There are several research implications of this review. There
is an apparent need for a transnational mixed method study
inclusive of low-, medium- and high-income countries, to
identify barriers and facilitators to implementation of ASPs using
a behavioral approach and to explore country, context and health
systems differences. Assuming that optimizing ASP efforts may
be effectively approached by addressing the commonly reported
influences on ASP implementation, an appropriate next step is
to identify strategies for optimizing ASPs that could, in turn,
change prescribing behavior of frontline healthcare professionals.
A wide range of behavior change approaches have been proposed,
for example, education, persuasion, incentivisation, coercion,
training, restriction, environmental restructuring, modeling or
enablement (Michie et al., 2014).
CONCLUSIONS
Despite a substantial research effort, and many quality
improvement initiatives, there is still a poor evidence base to
identify barriers and facilitators for establishing and maintaining
ASPs transnationally, even in developed countries where
most data comes from, and thus a poor basis for optimizing
these large-scale quality improvement efforts to address what is a
globally important problem. The reviewed here evidence suggests
that these efforts will likely require taking into account the
possibility of issues around inadequacy of information systems,
unavailability of key personnel and funding, and the competition
from other priority initiatives. To provide comprehensive
generalizable evidence on barriers and facilitators to establishing
and maintaining ASPs, a prospective transnational mixed
methods study with hospital staff using behavioral theory may be
worthwhile. For this purpose, we suggest using implementation
frameworks, for example TDF is well-suited to design ASP
interventions to enhance implementation and CFIR evaluation
of the implementation of a specific ASP in multi-level contexts.
This work enhances the evidence base to inform guidance
by taking a behavioral approach to identify influences on
ASP uptake.
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